← DXC Technology overview

DXC Technology vs CACI International: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

DXC Technology Co (DXC)

Q3 2026
▲2▼2

DXC's AI progress offset by revenue decline and legal probe

  • TCS trade secrets payment DXC collected $213.56 million from Tata Consultancy Services after a trade secrets ruling, a one-time cash boost that strengthens its balance sheet.

    This cash inflow was a major positive event in the quarter.

  • AI pivot and partnerships DXC advanced its AI pivot through partnerships with Anthropic, ElevenLabs, and Primary, and launched AI-native workplace and insurance tools, helping insurance software, SaaS, and AI revenue grow 24%.

    AI progress was a key positive driver for the stock.

  • Securities fraud investigation A securities fraud investigation tied to May’s earnings miss added legal uncertainty, weighing on investor sentiment.

    This legal issue was a significant negative factor during the quarter.

  • Revenue decline and weak guidance Revenue fell about 5% year over year, EPS missed estimates, and guidance pointed to a 3%–5% organic decline, suggesting AI progress may not durably lift the stock until shrinkage stops.

    Ongoing revenue decline and weak guidance pressured the stock.

August 2026
▲3▼1

DXC's AI pivot gains traction as insurance software grows, but revenue still shrinks

  • AI partnerships and new products build the turnaround story DXC added Anthropic, ElevenLabs and Primary partnerships plus AI-native workplace and insurance tools. These aim to shift DXC toward higher-value AI work, which could lift future sales and margins if clients adopt them. For now they are building blocks, not yet a fix for falling revenue.

    This is the core new strategic push that could change DXC's long-term growth trajectory.

  • Insurance software and AI revenue growing 24% DXC said recurring software, SaaS and AI revenue in its insurance business is growing 24%, supported by products like OASIS and Assure Smart Apps. This is a rare fast-growing piece inside a company whose overall revenue is shrinking, and it supports the idea that DXC can grow again.

    It is the clearest new evidence that part of DXC is actually growing, which investors care about.

  • Revenue keeps falling and profit missed expectations DXC's quarterly revenue fell about 5% from a year earlier and earnings per share missed analyst estimates, sending the stock down 6.6%. Management still guides organic revenue to decline 3% to 5% this fiscal year. Until that decline stops, the AI story alone may not lift the stock durably.

    It is the main counterweight: the core business is still shrinking and profit disappointed.

  • Accenture's strong outlook eased AI-disruption fears for IT services After Accenture reported better results and a solid outlook, DXC shares rose 5.7% in sympathy. The read-across signaled that AI is not hollowing out demand for traditional consulting and outsourcing as fast as some feared, which helps DXC's whole sector.

    It shows an external demand signal that directly moved DXC and the wider IT services group.

Latest
▲3▼1

DXC's AI pivot gains traction as insurance software grows, but revenue still shrinks

  • AI partnerships and new products build the turnaround story DXC added Anthropic, ElevenLabs and Primary partnerships plus AI-native workplace and insurance tools. These aim to shift DXC toward higher-value AI work, which could lift future sales and margins if clients adopt them. For now they are building blocks, not yet a fix for falling revenue.

    This is the core new strategic push that could change DXC's long-term growth trajectory.

  • Insurance software and AI revenue growing 24% DXC said recurring software, SaaS and AI revenue in its insurance business is growing 24%, supported by products like OASIS and Assure Smart Apps. This is a rare fast-growing piece inside a company whose overall revenue is shrinking, and it supports the idea that DXC can grow again.

    It is the clearest new evidence that part of DXC is actually growing, which investors care about.

  • Revenue keeps falling and profit missed expectations DXC's quarterly revenue fell about 5% from a year earlier and earnings per share missed analyst estimates, sending the stock down 6.6%. Management still guides organic revenue to decline 3% to 5% this fiscal year. Until that decline stops, the AI story alone may not lift the stock durably.

    It is the main counterweight: the core business is still shrinking and profit disappointed.

  • Accenture's strong outlook eased AI-disruption fears for IT services After Accenture reported better results and a solid outlook, DXC shares rose 5.7% in sympathy. The read-across signaled that AI is not hollowing out demand for traditional consulting and outsourcing as fast as some feared, which helps DXC's whole sector.

    It shows an external demand signal that directly moved DXC and the wider IT services group.

July 2026
▲2▼2

DXC's Weak Earnings and Legal Probe Weigh on Shares

  • Securities Fraud Investigation Pomerantz LLP is investigating DXC for possible securities fraud tied to its May 7 earnings miss, which already caused a 21% stock drop. The probe adds legal uncertainty and could lead to fines or lawsuits, making investors more cautious and pressuring the stock.

    This is a new legal risk that directly threatens DXC's finances and reputation, explaining recent price weakness.

  • Wins $213.56 Million in Trade Secrets Case DXC collected $213.56 million from Tata Consultancy Services after the Supreme Court upheld a trade secrets ruling. This cash boost strengthens DXC's balance sheet and shows it will defend its intellectual property, a positive for investors.

    This is a new, concrete financial gain that improves DXC's cash position and could support future investments.

  • Launches Private Cloud+ for Regulated Industries DXC launched Private Cloud+, a hybrid cloud solution for sensitive workloads in finance, healthcare, and government. This expands its product lineup and targets high-value clients, potentially boosting future revenue and showing innovation.

    This is a new product that could drive demand and revenue growth, a positive strategic move.

  • IBM Warning and Weak Q2 Earnings IBM's revenue warning signaled stalled enterprise deals, dragging DXC shares down 4.2%. Then DXC's Q2 adjusted EPS missed estimates by 11.3% and next-quarter revenue guidance was below expectations, sending shares down another 5.2%. These reinforce concerns about weak demand and execution.

    These are new negative developments that directly impact DXC's earnings and investor confidence, explaining recent price declines.

▲2▼2

DXC's Weak Earnings and Legal Probe Weigh on Shares

  • Securities Fraud Investigation Pomerantz LLP is investigating DXC for possible securities fraud tied to its May 7 earnings miss, which already caused a 21% stock drop. The probe adds legal uncertainty and could lead to fines or lawsuits, making investors more cautious and pressuring the stock.

    This is a new legal risk that directly threatens DXC's finances and reputation, explaining recent price weakness.

  • Wins $213.56 Million in Trade Secrets Case DXC collected $213.56 million from Tata Consultancy Services after the Supreme Court upheld a trade secrets ruling. This cash boost strengthens DXC's balance sheet and shows it will defend its intellectual property, a positive for investors.

    This is a new, concrete financial gain that improves DXC's cash position and could support future investments.

  • Launches Private Cloud+ for Regulated Industries DXC launched Private Cloud+, a hybrid cloud solution for sensitive workloads in finance, healthcare, and government. This expands its product lineup and targets high-value clients, potentially boosting future revenue and showing innovation.

    This is a new product that could drive demand and revenue growth, a positive strategic move.

  • IBM Warning and Weak Q2 Earnings IBM's revenue warning signaled stalled enterprise deals, dragging DXC shares down 4.2%. Then DXC's Q2 adjusted EPS missed estimates by 11.3% and next-quarter revenue guidance was below expectations, sending shares down another 5.2%. These reinforce concerns about weak demand and execution.

    These are new negative developments that directly impact DXC's earnings and investor confidence, explaining recent price declines.

CACI International Inc (CACI)

Q3 2026
▲2▼1

CACI wins big contracts, but debt from acquisitions weighs

  • Major contract wins boost backlog CACI won several large contracts, including a $500M drone-defense deal, a $400M Oracle federal HR partnership, and Space Force's NITE-STAR worth up to $981M, improving future revenue visibility.

    These wins are a key positive driver for the stock and new this period.

  • Strong Q2 results and raised guidance CACI beat estimates with Q2 revenue of $2.71B and EPS of $8.91, prompting management to raise its full-year guidance, signaling confidence in continued growth.

    Financial outperformance and raised outlook directly support the stock price.

  • Acquisitions double debt, interest costs jump Acquisitions totaling $2.64B nearly doubled long-term debt to $4.85B and raised interest expense by 35.6%, weighing on Q4 net income and EPS.

    This is a significant counterweight that pressures profitability and the stock.

September 2026
▲2▼1

CACI wins new defense contracts, but acquisition debt weighs

  • Q2 earnings beat and raised guidance CACI reported Q2 revenue of $2.71 billion and adjusted EPS of $8.91, both above estimates, and raised its fiscal 2027 EPS guidance to $33.41 at the midpoint, 8.4% above analyst expectations. This signals strong demand and profitability, pushing the stock up.

    This is a new earnings report that directly boosts investor confidence and the stock price.

  • New contract wins add to backlog CACI won several new contracts: a U.S. Space Force NITE-STAR award (up to $981 million), a $1.5 billion CENTCOM Apollo contract, and positions on Navy and DoD contracts worth up to $827.9 million and $275.9 million. These wins increase future revenue visibility and support the stock.

    These are new contract awards that directly drive future revenue and investor optimism.

  • Rising debt and interest costs from acquisitions CACI spent $2.64 billion on acquisitions in fiscal 2026, nearly doubling long-term debt to $4.85 billion and raising interest expense by 35.6%. This weighed on Q4 net income and EPS, which fell slightly, creating a counterweight to the positive contract news.

    This is a new financial development that negatively impacts profitability and investor sentiment.

Latest
▲2▼1

CACI wins new defense contracts, but acquisition debt weighs

  • Q2 earnings beat and raised guidance CACI reported Q2 revenue of $2.71 billion and adjusted EPS of $8.91, both above estimates, and raised its fiscal 2027 EPS guidance to $33.41 at the midpoint, 8.4% above analyst expectations. This signals strong demand and profitability, pushing the stock up.

    This is a new earnings report that directly boosts investor confidence and the stock price.

  • New contract wins add to backlog CACI won several new contracts: a U.S. Space Force NITE-STAR award (up to $981 million), a $1.5 billion CENTCOM Apollo contract, and positions on Navy and DoD contracts worth up to $827.9 million and $275.9 million. These wins increase future revenue visibility and support the stock.

    These are new contract awards that directly drive future revenue and investor optimism.

  • Rising debt and interest costs from acquisitions CACI spent $2.64 billion on acquisitions in fiscal 2026, nearly doubling long-term debt to $4.85 billion and raising interest expense by 35.6%. This weighed on Q4 net income and EPS, which fell slightly, creating a counterweight to the positive contract news.

    This is a new financial development that negatively impacts profitability and investor sentiment.

July 2026
▲4

CACI Wins $1.15B in New Contracts and Posts Strong FY26 Results

  • Army Contract Boost CACI secured a $140.5 million ceiling increase from the U.S. Army for forensic exploitation support, raising the total contract value to over $560 million. This steady demand for its services supports future revenue growth.

    This is a new contract win that directly boosts CACI's order book and future revenue.

  • Navy Modernization Contract CACI won a five-year, $113 million Navy contract to modernize Military Sealift Command's business systems, integrating AI and cybersecurity. This adds a steady stream of revenue and showcases CACI's tech capabilities.

    New contract award that expands CACI's work with the Navy and adds to backlog.

  • $500M Drone Defense Contract CACI landed a three-year, $500 million contract to provide its SkyValor drone defense systems to protect U.S. forces and infrastructure. This is a major product win that could drive significant revenue.

    Large new contract for CACI's proprietary product, indicating strong demand and future sales.

  • Oracle Federal HR Partnership CACI will partner with Oracle on a 10-year, $400 million federal HR modernization contract, helping consolidate systems for the Office of Personnel Management. This secures long-term work and strengthens CACI's position in federal IT services.

    New partnership and contract that adds a long-term revenue stream and enhances CACI's reputation.

▲4

CACI Wins $1.15B in New Contracts and Posts Strong FY26 Results

  • Army Contract Boost CACI secured a $140.5 million ceiling increase from the U.S. Army for forensic exploitation support, raising the total contract value to over $560 million. This steady demand for its services supports future revenue growth.

    This is a new contract win that directly boosts CACI's order book and future revenue.

  • Navy Modernization Contract CACI won a five-year, $113 million Navy contract to modernize Military Sealift Command's business systems, integrating AI and cybersecurity. This adds a steady stream of revenue and showcases CACI's tech capabilities.

    New contract award that expands CACI's work with the Navy and adds to backlog.

  • $500M Drone Defense Contract CACI landed a three-year, $500 million contract to provide its SkyValor drone defense systems to protect U.S. forces and infrastructure. This is a major product win that could drive significant revenue.

    Large new contract for CACI's proprietary product, indicating strong demand and future sales.

  • Oracle Federal HR Partnership CACI will partner with Oracle on a 10-year, $400 million federal HR modernization contract, helping consolidate systems for the Office of Personnel Management. This secures long-term work and strengthens CACI's position in federal IT services.

    New partnership and contract that adds a long-term revenue stream and enhances CACI's reputation.